We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News   May 17, 2018 | Original story from Sartorius

 
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

ambr® 250 bioreactor system

 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Clearest Ever Image of Ebola Virus Protein

News

The structure of a central component of the Ebola virus has been imaged for the first time at near-atomic resolution.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE